EX-21.1 4 exh211.htm EXHIBIT 21.1
Exhibit 21.1
Subsidiaries of Caladrius Biosciences, Inc.

Entity |  | Percentage of Ownership |  | Location
Caladrius Biosciences, Inc. |  | 100% |  | United States of America
NeoStem Therapies, Inc. |  | 100% |  | United States of America
Stem Cell Technologies, Inc. |  | 100% |  | United States of America
Amorcyte, LLC |  | 100% |  | United States of America
PCT, LLC, a Caladrius Company |  | 80.1% |  | United States of America
NeoStem Family Storage, LLC |  | 80.1% |  | United States of America
Athelos Corporation (1) |  | 97% |  | United States of America
PCT Allendale, LLC |  | 80.1% |  | United States of America
NeoStem Oncology, LLC |  | 100% |  | United States of America

(1) As of December 31, 2015, Becton Dickinson's ownership interest in Athelos Corporation was 2.8%.